Inhibition of KMO Ameliorates Myocardial Ischemia Injury via Maintaining Mitochondrial Fusion and Fission Balance

Looking for early diagnostic markers and therapeutic targets is the key to ensuring prompt treatment of myocardial ischemia (MI). Here, a novel biomarker xanthurenic acid (XA) was identified based on metabolomics and exhibited high sensitivity and specificity in the diagnosis of MI patients. Additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Qiong, Wu, Lingling, Dong, Shuhong, Zhu, Xiaozhou, Fan, Zhaoyang, Kou, Junping, Liu, Fuming, Yu, Boyang, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321280/
https://www.ncbi.nlm.nih.gov/pubmed/37416768
http://dx.doi.org/10.7150/ijbs.83392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321280/
https://www.ncbi.nlm.nih.gov/pubmed/37416768
http://dx.doi.org/10.7150/ijbs.83392

Ejemplares similares